TABLE 1. Hepatitis B vaccination policies and coverage with ≥3 doses of hepatitis B vaccine and with hepatitis B vaccine birth dose — worldwide, 2016–2020*.
| Variable | Countries, No. (%) |
||||
|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|
HepB vaccination policy†,§
| |||||
| Universal, infant |
186 (96) |
188 (97) |
189 (97) |
190 (98) |
190 (98) |
| Universal, children aged ≥1 yr |
3 (2) |
3 (2) |
2 (1) |
1 (1) |
1 (1) |
| Selective |
5 (3) |
3 (2) |
3 (2) |
3 (2) |
3 (2) |
|
HepB-BD vaccination policy†
| |||||
| Universal |
100 (52) |
104 (54) |
106 (55) |
109 (56) |
110 (57) |
| Selective |
34 (17) |
34 (18) |
34 (17) |
33 (17) |
33 (17) |
| HepB-BD not introduced |
60 (31) |
56 (29) |
54 (28) |
52 (27) |
51 (26) |
|
Immunization coverage
| |||||
| HepB3 coverage reported¶ |
185 (99) |
185 (98) |
186 (98) |
189 (99) |
189 (99) |
| HepB3 coverage ≥90%** |
116 (63) |
113 (61) |
116 (62) |
119 (63) |
98 (52) |
| Timely HepB-BD coverage†† reported§§ |
80 (80) |
90 (87) |
92 (87) |
96 (88) |
99 (90) |
| Timely HepB-BD coverage ≥90%¶¶ |
46 (58) |
46 (51) |
50 (54) |
53 (55) |
53 (54) |
| Both HepB3 and HepB-BD coverage reported† |
80 (41) |
90 (46) |
92 (47) |
96 (49) |
99 (51) |
| Both HepB3 and HepB-BD coverage ≥90%*** |
43 (54) |
42 (47) |
46 (50) |
51 (53) |
41 (41) |
|
HepB3 coverage, global and regional, %†††
| |||||
| Global |
84 |
84 |
84 |
85 |
82 |
|
Regions
|
|
|
|
|
|
| African |
73 |
74 |
74 |
75 |
73 |
| Americas |
88 |
84 |
83 |
79 |
81 |
| Eastern Mediterranean |
81 |
83 |
84 |
85 |
81 |
| European |
82 |
84 |
85 |
92 |
91 |
| South-East Asia |
89 |
90 |
90 |
91 |
86 |
| Western Pacific |
93 |
92 |
90 |
94 |
94 |
|
Timely HepB-BD coverage, global and regional, %†††
| |||||
| Global |
37 |
42 |
42 |
44 |
43 |
|
Regions†
| |||||
| African |
10 |
10 |
12 |
15 |
16 |
| Americas |
50 |
54 |
56 |
55 |
60 |
| Eastern Mediterranean |
20 |
33 |
33 |
33 |
33 |
| European§§§ |
41 |
41 |
42 |
44 |
43 |
| South-East Asia |
34 |
45 |
48 |
53 |
51 |
| Western Pacific | 83 | 84 | 83 | 84 | 81 |
Abbreviations: HepB = hepatitis B vaccine; HepB3 = third dose of HepB; HepB-BD = birth dose of HepB; WHO = World Health Organization.
† Among all 194 WHO member states. https://www.who.int/countries
§ HepB vaccination policy: universal = all persons in the applicable age group (i.e., all infants, children aged 1–12 years, or adolescents aged 13–15 years for routine HepB vaccination, and all newborns for HepB-BD) receive HepB; selective = only infants born to mothers with positive HBsAg test results receive HepB vaccination, starting with HepB-BD.
¶ Among countries with universal infant HepB vaccination policy.
** Among countries that reported HepB3 coverage.
†† Timely HepB-BD is defined as a dose of HepB given within 24 hours of birth.
§§ Among countries with universal HepB-BD policy.
¶¶ Among countries that reported HepB-BD coverage.
*** Among countries that reported both HepB3 and HepB-BD coverage.
††† Global or regional coverage = a weighted sum of WHO/UNICEF estimates of national coverage (WUENIC) by target population from the United Nations Population Division’s World Population Prospects.
§§§ For all countries in the European region, including 30 countries with selective HepB-BD policies that do not report HepB-BD coverage to WHO. This results in lower regional estimate than the actual coverage in countries with universal HepB-BD policies that report this information to WHO.